Psychiatric Hospitals Fail to Disclose FDA-Mandated Risks for Electroconvulsive Therapy Patients

GTTP

Over 50 psychiatric hospitals failed to implement mandatory FDA safety warnings for ECT patients.
Facilities frequently use misleading, non-scientific comparisons to promote high-voltage shock treatments.
Clinical evidence suggests a link between ECT and long-term cognitive damage or permanent memory loss.
Wide disparities in state laws leave vulnerable populations, including children, without adequate legal protection.

Impact - Why it Matters

This investigation exposes a systemic failure in medical transparency within the multi-billion dollar ECT industry. By highlighting the lack of informed consent and potential for permanent brain injury, this report challenges the ethics of current psychiatric practices and pressures regulators to prioritize patient safety over industry profitability.

Summary

A comprehensive review by the Citizens Commission on Human Rights (CCHR) International reveals that over 50 psychiatric hospitals across 23 states are failing to provide patients with mandatory safety disclosures regarding electroconvulsive therapy (ECT). Despite 2018 FDA requirements for updated patient labeling, these facilities consistently omit critical warnings concerning long-term memory loss, cardiovascular risks, and the fundamental right to refuse consent.

The report highlights that these institutions often promote ECT using misleading analogies, comparing high-voltage brain stimulation to simple household technology or dental procedures. With the industry estimated to be worth up to $7.6 billion, the findings suggest that many hospitals are prioritizing profitable, off-label treatments for conditions like autism and dementia, even as clinical data on safety and efficacy remains inconclusive and potentially harmful.

Legal and medical experts increasingly equate the effects of ECT to traumatic brain injury, citing evidence of permanent cognitive impairment in a significant number of recipients. As state regulations for involuntary treatment remain inconsistent and often nonexistent for minors, the CCHR is calling for immediate government intervention and a rigorous reevaluation of the role of ECT devices in modern psychiatric practice.

Psychiatric Hospitals Fail to Disclose FDA-Mandated Risks for Electroconvulsive Therapy Patients

GTTP

Over 50 psychiatric hospitals failed to implement mandatory FDA safety warnings for ECT patients.
Facilities frequently use misleading, non-scientific comparisons to promote high-voltage shock treatments.
Clinical evidence suggests a link between ECT and long-term cognitive damage or permanent memory loss.
Wide disparities in state laws leave vulnerable populations, including children, without adequate legal protection.